Vanguard Global Advisers »

Arbutus Biopharma shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $248k 55k 4.50

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Arbutus Biopharma

Morgan Stanley
Two Seas Capital
Whitefort Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Rubric Capital Management
State Street Corporation
Adage Capital Partners GP
Geode Capital Management
ADAR1 Capital Management
Legal & General Group
Woodline Partners
Leucadia National Corporation
BlackBarn Capital Partners

View all funds holding Arbutus Biopharma